ASTH
Astrana Health·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
Latest data update time: Updated on 2026-01-31
6.04 / 10Overall Score
OutperformInvestment Rating
6.04 / 10Overall Score
OutperformInvestment Rating
Is ASTH a Good Buy Right Now?
- Based on a composite score of 6.04/10, we rate ASTH as a Outperform. Our analysis breaks down into 9.43/10 for Fundamentals, 4.75/10 for Technicals, and 5.00/10 for Sentiment, indicating the stock is likely to See further upside.
Technical Analysis of ASTH?
Is ASTH undervalued or overvalued?
Is money flowing into or out of ASTH?
Is ASTH a Good Buy Right Now?
- Based on a composite score of 6.04/10, we rate ASTH as a Outperform. Our analysis breaks down into 9.43/10 for Fundamentals, 4.75/10 for Technicals, and 5.00/10 for Sentiment, indicating the stock is likely to See further upside.
Is ASTH undervalued or overvalued?
Technical Analysis of ASTH?
Is money flowing into or out of ASTH?
